Thompson Siegel & Walmsley’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-65,000
Closed -$515K – 360
2024
Q1
$515K Sell
65,000
-36,000
-36% -$283K 0.01% 302
2023
Q4
$829K Sell
101,000
-14,000
-12% -$109K 0.01% 278
2023
Q3
$773K Sell
115,000
-25,000
-18% -$158K 0.01% 282
2023
Q2
$806K Sell
140,000
-10,000
-7% -$52.7K 0.01% 282
2023
Q1
$618K Buy
150,000
+50,000
+50% +$226K 0.01% 290
2022
Q4
$411K Buy
100,000
+39,000
+64% +$167K 0.01% 298
2022
Q3
$245K Buy
+61,000
New +$288K ﹤0.01% 329

Other funds holding AVPT

Thompson Siegel & Walmsley's AVPT Position: Q2 2024 in Review

Thompson Siegel & Walmsley sold out of AvePoint (AVPT) in Q2 2024, closing a stake of 65,000 shares — an estimated $515K sold.

Thompson Siegel & Walmsley first reported a position in AVPT in Q3 2022 and held it in 7 quarters. The position peaked at $829K in Q4 2023. 175 funds tracked by Wall St. Rank hold AVPT as of Q2 2024.

  • Thompson Siegel & Walmsley reported no remaining AvePoint position as of Q2 2024 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 65,000 AvePoint shares in Q2 2024, an estimated $515K.
  • Thompson Siegel & Walmsley first reported a position in AvePoint in Q3 2022 and held it in 7 quarters.
  • Thompson Siegel & Walmsley's AvePoint position peaked at $829K in Q4 2023.
  • 175 funds tracked by Wall St. Rank held AvePoint as of Q2 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2024, filed 8 Aug 2024.